News
Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development
Cambridge, UK, 14 January 2025: Enhanc3D Genomics (‘Enhanced’…
14 January 2025/by Sophie MillerDr Chris Torrance – Interview with Dr Lara Marks
Earlier in the year, Dr Lara Marks, conducted interviews with…
7 June 2024/by Sophie MillerOne Brilliant Bootcamp
One Nucleus ran their inaugural Boston Bootcamp at the end of…
30 May 2024/by Kishen ChahwalaEnhanc3D Genomics appoints Hazel Jones as Chief Executive Officer
Cambridge, UK, 15 May 2024: Enhanc3D Genomics, a company developing…
15 May 2024/by Alex Scott-SimonsJ.P. Morgan’s 42nd Annual Healthcare Conference – Enhanc3D Genomics’ Chair Chris Torrance offers his perspective
J.P. Morgan’s 42nd Annual Healthcare Conference 2024 (JPM24)…
12 February 2024/by Kishen ChahwalaEnhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer
Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships
31 January 2024/by 3dgenoxdtEnhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer
Key appointment supports company growth and strategic commercial…
6 November 2023/by 3dgenoxdtEnhanc3D Genomics honoured at the Falling Walls 2023
Falling Walls 2023
We are honoured to be selected as a winner…
15 August 2023/by Kishen ChahwalaWe are honoured to be selected as a winner…
Enhanc3D Genomics raises £10 million in Series A financing to advance GenLink3D proprietary technology platform
GenLink3DTM provides the first high-resolution mapping of…
20 October 2022/by Alex Scott-SimonsOnHelix conference
We had a great day at OnHelix conference held at Babraham Institute focussed on translating research into diagnostics and therapeutics. #onhelix22 #3DGenomics
1 July 2022/by 3dgenoxdtENHANC3D was spun out of Professor Peter Fraser’s pioneering 3D genome organisation research laboratory
We are developing a technology to unlock the full potential of the 3D organisation of the #humangenome to identify #disease-associated #genetic interactions including those that are causal for disease susceptibility and progression.
1 June 2022/by 3dgenoxdtENHANC3D GENOMICS Awarded QuickFire Challenge Grant
We are proud to be awarded the Johnson & Johnson Innovation QuickFire Challenge Grant which recognises the potential of our functional genomics platform, GenLink3D™.
26 March 2022/by 3dgenoxdt